ArticleGenes & diseases2024

Overcoming adaptive resistance in AML by synergistically targeting FOXO3A-GNG7-mTOR axis with FOXO3A inhibitor Gardenoside and rapamycin.

Zhe Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.